Regulation of nucleocytoplasmic trafficking of viral proteins: An integral role in pathogenesis?

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1813, Issue 12, 2011, Pages 2176-2190

  Fulcher, Alex J ^a   Jans, David A ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b Australian Government Australian Research Council   (Australia)

Author keywords

Human cytomegalovirus ppUL44; Human papillomavirus E1; Nuclear import; Phosphorylation; Rabies virus P; Simian virus 40 T ag

Indexed keywords

ANTIVIRUS AGENT; BINDING PROTEIN; BRCA1 ASSOCIATED PROTEIN 2; CASEIN KINASE I; CASEIN KINASE II; E1A PROTEIN; EXPORTIN 1; GLYCINE DEHYDROGENASE (DECARBOXYLATING); GLYCOGEN SYNTHASE KINASE 3; GLYCOPROTEIN E1; I KAPPA B; I KAPPA B KINASE GAMMA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMPORTIN BETA1; KARYOPHERIN ALPHA; KARYOPHERIN BETA; NUCLEOPORIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROCESSIVITY FACTOR PPUL44; PROTEIN P110; PROTEIN P53; RAN BINDING PROTEIN 1; RAN PROTEIN; REX PROTEIN; STAT1 PROTEIN; SURVIVIN; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS LARGE T ANTIGEN; VIRUS PROTEIN; VIRUS PROTEIN V;

ACETYLATION; AMINO ACID SUBSTITUTION; BINDING SITE; CELL NUCLEUS MEMBRANE; CELLULAR DISTRIBUTION; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; CYTOPLASM; DIMERIZATION; DNA REPLICATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 2; IMMUNE RESPONSE; INTERMOLECULAR MASKING; MOLECULAR INTERACTION; NONHUMAN; NUCLEAR EXPORT SIGNAL; NUCLEAR IMPORT; NUCLEAR LOCALIZATION SIGNAL; NUCLEAR PORE COMPLEX; NUCLEOCYTOPLASMIC TRANSPORT; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; PROTEIN TRANSPORT; RABIES VIRUS; REVIEW; SIGNAL TRANSDUCTION; SIMIAN VIRUS 40; SUMOYLATION; UBIQUITINATION; UPREGULATION; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS INHIBITION; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS VIRULENCE; WART VIRUS;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; HUMANS; VIRAL PROTEINS; VIRUS DISEASES;

HUMAN HERPESVIRUS 5; HUMAN PAPILLOMAVIRUS; RABIES VIRUS; RNA VIRUSES; SIMIAE; SIMIAN VIRUS 40;

EID: 80051922904     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2011.03.019     Document Type: Review

References (225)

1. Mosammaparast N., Pemberton L.F. Karyopherins: from nuclear-transport mediators to nuclear-function regulators. Trends Cell Biol. 2004, 14:547-556.
2. Suntharalingam M., Wente S.R. Peering through the pore: nuclear pore complex structure, assembly, and function. Dev. Cell 2003, 4:775-789.
3. Gorlich D., Kutay U. Transport between the cell nucleus and the cytoplasm. Annu. Rev. Cell Dev. Biol. 1999, 15:607-660.
4. Jans D.A., Xiao C.Y., Lam M.H. Nuclear targeting signal recognition: a key control point in nuclear transport?. Bioessays 2000, 22:532-544.
5. Brohawn S.G., Partridge J.R., Whittle J.R., Schwartz T.U. The nuclear pore complex has entered the atomic age. Structure 2009, 17:1156-1168.
6. D'Angelo M.A., Hetzer M.W. Structure, dynamics and function of nuclear pore complexes. Trends Cell Biol. 2008, 18:456-466.
7. Gorlich D., Mattaj I.W. Nucleocytoplasmic transport. Science 1996, 271:1513-1518.
8. Hinshaw J.E., Carragher B.O., Milligan R.A. Architecture and design of the nuclear pore complex. Cell 1992, 69:1133-1141.
9. Terry L.J., Wente S.R. Flexible gates: dynamic topologies and functions for FG nucleoporins in nucleocytoplasmic transport. Eukaryot. Cell 2009, 8:1814-1827.
10. Tran E.J., Wente S.R. Dynamic nuclear pore complexes: life on the edge. Cell 2006, 125:1041-1053.
11. Rout M.P., Aitchison J.D. Pore relations: nuclear pore complexes and nucleocytoplasmic exchange. Essays Biochem. 2000, 36:75-88.
12. Walde S., Kehlenbach R.H. The Part and the Whole: functions of nucleoporins in nucleocytoplasmic transport. Trends Cell Biol. 2010, 20:461-469.
13. Frey S., Richter R.P., Gorlich D. FG-rich repeats of nuclear pore proteins form a three-dimensional meshwork with hydrogel-like properties. Science 2006, 314:815-817.
14. Lim R.Y., Huang N.P., Koser J., Deng J., Lau K.H., Schwarz-Herion K., Fahrenkrog B., Aebi U. Flexible phenylalanine-glycine nucleoporins as entropic barriers to nucleocytoplasmic transport. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:9512-9517.
15. Peters R. Translocation through the nuclear pore complex: selectivity and speed by reduction-of-dimensionality. Traffic 2005, 6:421-427.
16. Rout M.P., Aitchison J.D., Suprapto A., Hjertaas K., Zhao Y., Chait B.T. The yeast nuclear pore complex: composition, architecture, and transport mechanism. J. Cell Biol. 2000, 148:635-651.
17. Fried H., Kutay U. Nucleocytoplasmic transport: taking an inventory. Cell. Mol. Life Sci. 2003, 60:1659-1688.
18. Goldfarb D.S., Corbett A.H., Mason D.A., Harreman M.T., Adam S.A. Importin alpha: a multipurpose nuclear-transport receptor. Trends Cell Biol. 2004, 14:505-514.
19. Pemberton L.F., Paschal B.M. Mechanisms of receptor-mediated nuclear import and nuclear export. Traffic 2005, 6:187-198.
20. Weis K. Regulating access to the genome: nucleocytoplasmic transport throughout the cell cycle. Cell 2003, 112:441-451.
21. Kalderon D., Richardson W.D., Markham A.F., Smith A.E. Sequence requirements for nuclear location of simian virus 40 large-T antigen. Nature 1984, 311:33-38.
22. Kalderon D., Roberts B.L., Richardson W.D., Smith A.E. A short amino acid sequence able to specify nuclear location. Cell 1984, 39:499-509.
23. Alvisi G., Jans D.A., Guo J., Pinna L.A., Ripalti A. A protein kinase CK2 site flanking the nuclear targeting signal enhances nuclear transport of human cytomegalovirus ppUL44. Traffic 2005, 6:1002-1013.
24. Yu J.H., Lin B.Y., Deng W., Broker T.R., Chow L.T. Mitogen-activated protein kinases activate the nuclear localization sequence of human papillomavirus type 11 E1 DNA helicase to promote efficient nuclear import. J. Virol. 2007, 81:5066-5078.
25. Johnson A.W., Lund E., Dahlberg J. Nuclear export of ribosomal subunits. Trends Biochem. Sci. 2002, 27:580-585.
26. Ohno M., Segref A., Bachi A., Wilm M., Mattaj I.W. PHAX, a mediator of U snRNA nuclear export whose activity is regulated by phosphorylation. Cell 2000, 101:187-198.
27. Paraskeva E., Izaurralde E., Bischoff F.R., Huber J., Kutay U., Hartmann E., Luhrmann R., Gorlich D. CRM1-mediated recycling of snurportin 1 to the cytoplasm. J. Cell Biol. 1999, 145:255-264.
28. Fischer U., Huber J., Boelens W.C., Mattaj I.W., Luhrmann R. The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 1995, 82:475-483.
29. Hutten S., Walde S., Spillner C., Hauber J., Kehlenbach R.H. The nuclear pore component Nup358 promotes transportin-dependent nuclear import. J. Cell Sci. 2009, 122:1100-1110.
30. Hutten S., Flotho A., Melchior F., Kehlenbach R.H. The Nup358-RanGAP complex is required for efficient importin alpha/beta-dependent nuclear import. Mol. Biol. Cell 2008, 19:2300-2310.
31. Pyhtila B., Rexach M. A gradient of affinity for the karyopherin Kap95p along the yeast nuclear pore complex. J. Biol. Chem. 2003, 278:42699-42709.
32. Oka M., Asally M., Yasuda Y., Ogawa Y., Tachibana T., Yoneda Y. The mobile FG nucleoporin Nup98 is a cofactor for Crm1-dependent protein export. Mol. Biol. Cell 2010, 21:1885-1896.
33. Ben-Efraim I., Frosst P.D., Gerace L. Karyopherin binding interactions and nuclear import mechanism of nuclear pore complex protein Tpr. BMC Cell Biol. 2009, 10:74.
34. Hutten S., Kehlenbach R.H. Nup214 is required for CRM1-dependent nuclear protein export in vivo. Mol. Cell. Biol. 2006, 26:6772-6785.
35. Hogarth C.A., Calanni S., Jans D.A., Loveland K.L. Importin alpha mRNAs have distinct expression profiles during spermatogenesis. Dev. Dyn. 2006, 235:253-262.
36. Loveland K.L., Hogarth C., Szczepny A., Prabhu S.M., Jans D.A. Expression of nuclear transport importins beta 1 and beta 3 is regulated during rodent spermatogenesis. Biol. Reprod. 2006, 74:67-74.
37. Jans D.A., Hubner S. Regulation of protein transport to the nucleus: central role of phosphorylation. Physiol. Rev. 1996, 76:651-685.
38. Poon I.K., Jans D.A. Regulation of nuclear transport: central role in development and transformation?. Traffic 2005, 6:173-186.
39. Durairaj G., Garg P., Bhaumik S.R. Nuclear export of mRNA and its regulation by ubiquitylation. RNA Biol. 2009, 6:531-535.
40. Palancade B., Doye V. Sumoylating and desumoylating enzymes at nuclear pores: underpinning their unexpected duties?. Trends Cell Biol. 2008, 18:174-183.
41. Sim H., Argentaro A., Harley V.R. Boys, girls and shuttling of SRY and SOX9. Trends Endocrinol. Metab. 2008, 19:213-222.
42. Pickard A., Wong P.P., McCance D.J. Acetylation of Rb by PCAF is required for nuclear localization and keratinocyte differentiation. J. Cell Sci. 2010, 123:3718-3726.
43. Wang H., Holloway M.P., Ma L., Cooper Z.A., Riolo M., Samkari A., Elenitoba-Johnson K.S., Chin Y.E., Altura R.A. Acetylation directs survivin nuclear localization to repress STAT3 oncogenic activity. J. Biol. Chem. 2010, 285:36129-36137.
44. Lohrum M.A., Woods D.B., Ludwig R.L., Balint E., Vousden K.H. C-terminal ubiquitination of p53 contributes to nuclear export. Mol. Cell. Biol. 2001, 21:8521-8532.
45. Li M., Brooks C.L., Wu-Baer F., Chen D., Baer R., Gu W. Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science 2003, 302:1972-1975.
46. Trotman L.C., Wang X., Alimonti A., Chen Z., Teruya-Feldstein J., Yang H., Pavletich N.P., Carver B.S., Cordon-Cardo C., Erdjument-Bromage H., Tempst P., Chi S.G., Kim H.J., Misteli T., Jiang X., Pandolfi P.P. Ubiquitination regulates PTEN nuclear import and tumor suppression. Cell 2007, 128:141-156.
47. Shcherbik N., Haines D.S. Ub on the move. J. Cell. Biochem. 2004, 93:11-19.
48. Huang T.T., Wuerzberger-Davis S.M., Wu Z.H., Miyamoto S. Sequential modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-kappaB activation by genotoxic stress. Cell 2003, 115:565-576.
49. Terry L.J., Shows E.B., Wente S.R. Crossing the nuclear envelope: hierarchical regulation of nucleocytoplasmic transport. Science 2007, 318:1412-1416.
50. Ghildyal R., Jordan B., Li D., Dagher H., Bardin P.G., Gern J.E., Jans D.A. Rhinovirus 3C protease can localize in the nucleus and alter active and passive nucleocytoplasmic transport. J. Virol. 2009, 83:7349-7352.
51. Belov G.A., Lidsky P.V., Mikitas O.V., Egger D., Lukyanov K.A., Bienz K., Agol V.I. Bidirectional increase in permeability of nuclear envelope upon poliovirus infection and accompanying alterations of nuclear pores. J. Virol. 2004, 78:10166-10177.
52. Gustin K.E., Sarnow P. Effects of poliovirus infection on nucleo-cytoplasmic trafficking and nuclear pore complex composition. EMBO J. 2001, 20:240-249.
53. Gustin K.E., Sarnow P. Inhibition of nuclear import and alteration of nuclear pore complex composition by rhinovirus. J. Virol. 2002, 76:8787-8796.
54. Park N., Katikaneni P., Skern T., Gustin K.E. Differential targeting of nuclear pore complex proteins in poliovirus-infected cells. J. Virol. 2008, 82:1647-1655.
55. Basler C.F., Amarasinghe G.K. Evasion of interferon responses by Ebola and Marburg viruses. J. Interferon Cytokine Res. 2009, 29:511-520.
56. Mateo M., Reid S.P., Leung L.W., Basler C.F., Volchkov V.E. Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling. J. Virol. 2010, 84:1169-1175.
57. Reid S.P., Leung L.W., Hartman A.L., Martinez O., Shaw M.L., Carbonnelle C., Volchkov V.E., Nichol S.T., Basler C.F. Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. J. Virol. 2006, 80:5156-5167.
58. Frieman M., Yount B., Heise M., Kopecky-Bromberg S.A., Palese P., Baric R.S. Severe acute respiratory syndrome coronavirus ORF6 antagonizes STAT1 function by sequestering nuclear import factors on the rough endoplasmic reticulum/Golgi membrane. J. Virol. 2007, 81:9812-9824.
59. Randall R.E., Goodbourn S. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 2008, 89:1-47.
60. Lyons R.H., Ferguson B.Q., Rosenberg M. Pentapeptide nuclear localization signal in adenovirus E1a. Mol. Cell. Biol. 1987, 7:2451-2456.
61. Kohler M., Gorlich D., Hartmann E., Franke J. Adenoviral E1A protein nuclear import is preferentially mediated by importin alpha3 in vitro. Virology 2001, 289:186-191.
62. Madison D.L., Yaciuk P., Kwok R.P., Lundblad J.R. Acetylation of the adenovirus-transforming protein E1A determines nuclear localization by disrupting association with importin-alpha. J. Biol. Chem. 2002, 277:38755-38763.
63. Zhang Q., Yao H., Vo N., Goodman R.H. Acetylation of adenovirus E1A regulates binding of the transcriptional corepressor CtBP. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:14323-14328.
64. Douglas J.L., Quinlan M.P. Efficient nuclear localization of the Ad5 E1A 12S protein is necessary for immortalization but not cotransformation of primary epithelial cells. Cell Growth Differ. 1994, 5:475-483.
65. Lentz M.R., Pak D., Mohr I., Botchan M.R. The E1 replication protein of bovine papillomavirus type 1 contains an extended nuclear localization signal that includes a p34cdc2 phosphorylation site. J. Virol. 1993, 67:1414-1423.
66. Leng X., Wilson V.G. Genetically defined nuclear localization signal sequence of bovine papillomavirus E1 protein is necessary and sufficient for the nuclear localization of E1-beta-galactosidase fusion proteins. J. Gen. Virol. 1994, 75(Pt 9):2463-2467.
67. Bian X.L., Rosas-Acosta G., Wu Y.C., Wilson V.G. Nuclear import of bovine papillomavirus type 1 E1 protein is mediated by multiple alpha importins and is negatively regulated by phosphorylation near a nuclear localization signal. J. Virol. 2007, 81:2899-2908.
68. Cueille N., Nougarede R., Mechali F., Philippe M., Bonne-Andrea C. Functional interaction between the bovine papillomavirus virus type 1 replicative helicase E1 and cyclin E-Cdk2. J. Virol. 1998, 72:7255-7262.
69. Zanardi T.A., Stanley C.M., Saville B.M., Spacek S.M., Lentz M.R. Modulation of bovine papillomavirus DNA replication by phosphorylation of the viral E1 protein. Virology 1997, 228:1-10.
70. Ambinder R.F., Mullen M.A., Chang Y.N., Hayward G.S., Hayward S.D. Functional domains of Epstein-Barr virus nuclear antigen EBNA-1. J. Virol. 1991, 65:1466-1478.
71. Ito S., Ikeda M., Kato N., Matsumoto A., Ishikawa Y., Kumakubo S., Yanagi K. Epstein-Barr virus nuclear antigen-1 binds to nuclear transporter karyopherin alpha1/NPI-1 in addition to karyopherin alpha2/Rch1. Virology 2000, 266:110-119.
72. Kitamura R., Sekimoto T., Ito S., Harada S., Yamagata H., Masai H., Yoneda Y., Yanagi K. Nuclear import of Epstein-Barr virus nuclear antigen 1 mediated by NPI-1 (Importin alpha5) is up- and down-regulated by phosphorylation of the nuclear localization signal for which Lys379 and Arg380 are essential. J. Virol. 2006, 80:1979-1991.
73. Leung C.S., Haigh T.A., Mackay L.K., Rickinson A.B., Taylor G.S. Nuclear location of an endogenously expressed antigen, EBNA1, restricts access to macroautophagy and the range of CD4 epitope display. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:2165-2170.
74. Leung C.S., Taylor G.S. Nuclear shelter: the influence of subcellular location on the processing of antigens by macroautophagy. Autophagy 2010, 6.
75. Mears W.E., Lam V., Rice S.A. Identification of nuclear and nucleolar localization signals in the herpes simplex virus regulatory protein ICP27. J. Virol. 1995, 69:935-947.
76. Zhi Y., Sandri-Goldin R.M. Analysis of the phosphorylation sites of herpes simplex virus type 1 regulatory protein ICP27. J. Virol. 1999, 73:3246-3257.
77. Rojas S., Corbin-Lickfett K.A., Escudero-Paunetto L., Sandri-Goldin R.M. ICP27 phosphorylation site mutants are defective in herpes simplex virus 1 replication and gene expression. J. Virol. 2010, 84:2200-2211.
78. Fulcher A.J., Roth D.M., Fatima S., Alvisi G., Jans D.A. The BRCA-1 binding protein BRAP2 is a novel, negative regulator of nuclear import of viral proteins, dependent on phosphorylation flanking the nuclear localization signal. FASEB J. 2010, 24:1454-1466.
79. Ertl P.F., Powell K.L. Physical and functional interaction of human cytomegalovirus DNA polymerase and its accessory protein (ICP36) expressed in insect cells. J. Virol. 1992, 66:4126-4133.
80. Ripalti A., Boccuni M.C., Campanini F., Landini M.P. Cytomegalovirus-mediated induction of antisense mRNA expression to UL44 inhibits virus replication in an astrocytoma cell line: identification of an essential gene. J. Virol. 1995, 69:2047-2057.
81. Pari G.S., Kacica M.A., Anders D.G. Open reading frames UL44, IRS1/TRS1, and UL36-38 are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA synthesis. J. Virol. 1993, 67:2575-2582.
82. Shen W., Westgard E., Huang L., Ward M.D., Osborn J.L., Chau N.H., Collins L., Marcum B., Koach M.A., Bibbs J., Semmes O.J., Kerry J.A. Nuclear trafficking of the human cytomegalovirus pp 71 (ppUL82) tegument protein. Virology 2008, 376:42-52.
83. Penkert R.R., Kalejta R.F. Nuclear localization of tegument-delivered pp 71 in human cytomegalovirus-infected cells is facilitated by one or more factors present in terminally differentiated fibroblasts. J. Virol. 2010, 84:9853-9863.
84. Deng W., Lin B.Y., Jin G., Wheeler C.G., Ma T., Harper J.W., Broker T.R., Chow L.T. Cyclin/CDK regulates the nucleocytoplasmic localization of the human papillomavirus E1 DNA helicase. J. Virol. 2004, 78:13954-13965.
85. Hubner S., Xiao C.Y., Jans D.A. The protein kinase CK2 site (Ser111/112) enhances recognition of the simian virus 40 large T-antigen nuclear localization sequence by importin. J. Biol. Chem. 1997, 272:17191-17195.
86. Jans D.A., Ackermann M.J., Bischoff J.R., Beach D.H., Peters R. p34cdc2-mediated phosphorylation at T124 inhibits nuclear import of SV-40 T antigen proteins. J. Cell Biol. 1991, 115:1203-1212.
87. Jans D.A., Jans P. Negative charge at the casein kinase II site flanking the nuclear localization signal of the SV40 large T-antigen is mechanistically important for enhanced nuclear import. Oncogene 1994, 9:2961-2968.
88. Rihs H.P., Jans D.A., Fan H., Peters R. The rate of nuclear cytoplasmic protein transport is determined by the casein kinase II site flanking the nuclear localization sequence of the SV40 T-antigen. EMBO J. 1991, 10:633-639.
89. Rihs H.P., Peters R. Nuclear transport kinetics depend on phosphorylation-site-containing sequences flanking the karyophilic signal of the Simian virus 40 T-antigen. EMBO J. 1989, 8:1479-1484.
90. Xiao C.Y., Hubner S., Jans D.A. SV40 large tumor antigen nuclear import is regulated by the double-stranded DNA-dependent protein kinase site (serine 120) flanking the nuclear localization sequence. J. Biol. Chem. 1997, 272:22191-22198.
91. Grasser F.A., Scheidtmann K.H., Tuazon P.T., Traugh J.A., Walter G. In vitro phosphorylation of SV40 large T antigen. Virology 1988, 165:13-22.
92. Fulcher A.J., Dias M.M., Jans D.A. Binding of p110 retinoblastoma protein inhibits nuclear import of simian virus SV40 large tumor antigen. J. Biol. Chem. 2010, 285:17744-17753.
93. Schneider J., Fanning E. Mutations in the phosphorylation sites of simian virus 40 (SV40) T antigen alter its origin DNA-binding specificity for sites I or II and affect SV40 DNA replication activity. J. Virol. 1988, 62:1598-1605.
94. Kinchington P.R., Turse S.E. Regulated nuclear localization of the varicella-zoster virus major regulatory protein, IE62. J. Infect. Dis. 1998, 178(Suppl 1):S16-S21.
95. Kinchington P.R., Fite K., Seman A., Turse S.E. Virion association of IE62, the varicella-zoster virus (VZV) major transcriptional regulatory protein, requires expression of the VZV open reading frame 66 protein kinase. J. Virol. 2001, 75:9106-9113.
96. Kinchington P.R., Fite K., Turse S.E. Nuclear accumulation of IE62, the varicella-zoster virus (VZV) major transcriptional regulatory protein, is inhibited by phosphorylation mediated by the VZV open reading frame 66 protein kinase. J. Virol. 2000, 74:2265-2277.
97. Eisfeld A.J., Turse S.E., Jackson S.A., Lerner E.C., Kinchington P.R. Phosphorylation of the varicella-zoster virus (VZV) major transcriptional regulatory protein IE62 by the VZV open reading frame 66 protein kinase. J. Virol. 2006, 80:1710-1723.
98. Schaap A., Fortin J.F., Sommer M., Zerboni L., Stamatis S., Ku C.C., Nolan G.P., Arvin A.M. T-cell tropism and the role of ORF66 protein in pathogenesis of varicella-zoster virus infection. J. Virol. 2005, 79:12921-12933.
99. Chida K., Vogt P.K. Nuclear translocation of viral Jun but not of cellular Jun is cell cycle dependent. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:4290-4294.
100. Tagawa T., Kuroki T., Vogt P.K., Chida K. The cell cycle-dependent nuclear import of v-Jun is regulated by phosphorylation of a serine adjacent to the nuclear localization signal. J. Cell Biol. 1995, 130:255-263.
101. Schlummer S., Vetter R., Kuder N., Henkel A., Chen Y.X., Li Y.M., Kuhlmann J., Waldmann H. Influence of serine O-glycosylation or O-phosphorylation close to the vJun nuclear localisation sequence on nuclear import. Chembiochem 2006, 7:88-97.
102. Wong W.Y., Havarstein L.S., Morgan I.M., Vogt P.K. c-Jun causes focus formation and anchorage-independent growth in culture but is non-tumorigenic. Oncogene 1992, 7:2077-2080.
103. Morgan I.M., Havarstein L.S., Wong W.Y., Luu P., Vogt P.K. Efficient induction of fibrosarcomas by v-jun requires mutations in the DNA binding region and the transactivation domain. Oncogene 1994, 9:2793-2797.
104. Siomi H., Shida H., Nam S.H., Nosaka T., Maki M., Hatanaka M. Sequence requirements for nucleolar localization of human T cell leukemia virus type I pX protein, which regulates viral RNA processing. Cell 1988, 55:197-209.
105. Palmeri D., Malim M.H. Importin beta can mediate the nuclear import of an arginine-rich nuclear localization signal in the absence of importin alpha. Mol. Cell. Biol. 1999, 19:1218-1225.
106. Truant R., Cullen B.R. The arginine-rich domains present in human immunodeficiency virus type 1 Tat and Rev function as direct importin beta-dependent nuclear localization signals. Mol. Cell. Biol. 1999, 19:1210-1217.
107. Kesic M., Ward M., Semmes O.J., Green P.L. Site-specific phosphorylation regulates human T-cell leukemia virus type 2 Rex function in vivo. J. Virol. 2009, 83:8859-8868.
108. Narayan M., Kusuhara K., Green P.L. Phosphorylation of two serine residues regulates human T-cell leukemia virus type 2 Rex function. J. Virol. 2001, 75:8440-8448.
109. Narayan M., Younis I., D'Agostino D.M., Green P.L. Functional domain structure of human T-cell leukemia virus type 2 rex. J. Virol. 2003, 77:12829-12840.
110. Wang Y.E., Park A., Lake M., Pentecost M., Torres B., Yun T.E., Wolf M.C., Holbrook M.R., Freiberg A.N., Lee B. Ubiquitin-regulated nuclear-cytoplasmic trafficking of the nipah virus matrix protein is important for viral budding. PLoS Pathog. 2010, 6:e1001186.
111. Jiang H., Olson M.V., Medrano D.R., Lee O.H., Xu J., Piao Y., Alonso M.M., Gomez-Manzano C., Hung M.C., Yung W.K., Fueyo J. A novel CRM1-dependent nuclear export signal in adenoviral E1A protein regulated by phosphorylation. FASEB J. 2006, 20:2603-2605.
112. Hsu C.Y., Mechali F., Bonne-Andrea C. Nucleocytoplasmic shuttling of bovine papillomavirus E1 helicase downregulates viral DNA replication in S phase. J. Virol. 2007, 81:384-394.
113. Rosas-Acosta G., Wilson V.G. Identification of a nuclear export signal sequence for bovine papillomavirus E1 protein. Virology 2008, 373:149-162.
114. Poon I.K., Oro C., Dias M.M., Zhang J., Jans D.A. Apoptin nuclear accumulation is modulated by a CRM1-recognized nuclear export signal that is active in normal but not in tumor cells. Cancer Res. 2005, 65:7059-7064.
115. Kuusisto H.V., Wagstaff K.M., Alvisi G., Jans D.A. The C-terminus of apoptin represents a unique tumor cell-enhanced nuclear targeting module. Int. J. Cancer 2008, 123:2965-2969.
116. Prasetyo A.A., Kamahora T., Kuroishi A., Murakami K., Hino S. Replication of chicken anemia virus (CAV) requires apoptin and is complemented by VP3 of human torque teno virus (TTV). Virology 2009, 385:85-92.
117. Ma T., Zou N., Lin B.Y., Chow L.T., Harper J.W. Interaction between cyclin-dependent kinases and human papillomavirus replication-initiation protein E1 is required for efficient viral replication. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:382-387.
118. Munoz-Fontela C., Collado M., Rodriguez E., Garcia M.A., Alvarez-Barrientos A., Arroyo J., Nombela C., Rivas C. Identification of a nuclear export signal in the KSHV latent protein LANA2 mediating its export from the nucleus. Exp. Cell Res. 2005, 311:96-105.
119. Marcos-Villar L., Lopitz-Otsoa F., Gallego P., Munoz-Fontela C., Gonzalez-Santamaria J., Campagna M., Shou-Jiang G., Rodriguez M.S., Rivas C. Kaposi's sarcoma-associated herpesvirus protein LANA2 disrupts PML oncogenic domains and inhibits PML-mediated transcriptional repression of the survivin gene. J. Virol. 2009, 83:8849-8858.
120. Pasdeloup D., Poisson N., Raux H., Gaudin Y., Ruigrok R.W., Blondel D. Nucleocytoplasmic shuttling of the rabies virus P protein requires a nuclear localization signal and a CRM1-dependent nuclear export signal. Virology 2005, 334:284-293.
121. Moseley G.W., Filmer R.P., DeJesus M.A., Jans D.A. Nucleocytoplasmic distribution of rabies virus P-protein is regulated by phosphorylation adjacent to C-terminal nuclear import and export signals. Biochemistry 2007, 46:12053-12061.
122. Mavrakis M., McCarthy A.A., Roche S., Blondel D., Ruigrok R.W. Structure and function of the C-terminal domain of the polymerase cofactor of rabies virus. J. Mol. Biol. 2004, 343:819-831.
123. Shimizu K., Ito N., Mita T., Yamada K., Hosokawa-Muto J., Sugiyama M., Minamoto N. Involvement of nucleoprotein, phosphoprotein, and matrix protein genes of rabies virus in virulence for adult mice. Virus Res. 2007, 123:154-160.
124. Ito N., Moseley G.W., Blondel D., Shimizu K., Rowe C.L., Ito Y., Masatani T., Nakagawa K., Jans D.A., Sugiyama M. Role of interferon antagonist activity of rabies virus phosphoprotein in viral pathogenicity. J. Virol. 2010, 84:6699-6710.
125. Ghildyal R., Ho A., Dias M., Soegiyono L., Bardin P.G., Tran K.C., Teng M.N., Jans D.A. The respiratory syncytial virus matrix protein possesses a Crm1-mediated nuclear export mechanism. J. Virol. 2009, 83:5353-5362.
126. Beg A.A., Ruben S.M., Scheinman R.I., Haskill S., Rosen C.A., Baldwin A.S. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention. Genes Dev. 1992, 6:1899-1913.
127. Traenckner E.B., Wilk S., Baeuerle P.A. A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B. EMBO J. 1994, 13:5433-5441.
128. Bischoff J.R., Friedman P.N., Marshak D.R., Prives C., Beach D. Human p53 is phosphorylated by p60-cdc2 and cyclin B-cdc2. Proc. Natl. Acad. Sci. U.S.A. 1990, 87:4766-4770.
129. Liang S.H., Clarke M.F. Regulation of p53 localization. Eur. J. Biochem. 2001, 268:2779-2783.
130. Kim I.S., Kim D.H., Han S.M., Chin M.U., Nam H.J., Cho H.P., Choi S.Y., Song B.J., Kim E.R., Bae Y.S., Moon Y.H. Truncated form of importin alpha identified in breast cancer cell inhibits nuclear import of p53. J. Biol. Chem. 2000, 275:23139-23145.
131. Child E.S., Mann D.J. The intricacies of p21 phosphorylation: protein/protein interactions, subcellular localization and stability. Cell Cycle 2006, 5:1313-1319.
132. Rodriguez-Vilarrupla A., Diaz C., Canela N., Rahn H.P., Bachs O., Agell N. Identification of the nuclear localization signal of p21(cip1) and consequences of its mutation on cell proliferation. FEBS Lett. 2002, 531:319-323.
133. Asada M., Ohmi K., Delia D., Enosawa S., Suzuki S., Yuo A., Suzuki H., Mizutani S. Brap2 functions as a cytoplasmic retention protein for p21 during monocyte differentiation. Mol. Cell. Biol. 2004, 24:8236-8243.
134. Ali S.H., DeCaprio J.A. Cellular transformation by SV40 large T antigen: interaction with host proteins. Semin. Cancer Biol. 2001, 11:15-23.
135. Garcea R.L., Imperiale M.J. Simian virus 40 infection of humans. J. Virol. 2003, 77:5039-5045.
136. Kierstead T.D., Tevethia M.J. Association of p53 binding and immortalization of primary C57BL/6 mouse embryo fibroblasts by using simian virus 40 T-antigen mutants bearing internal overlapping deletion mutations. J. Virol. 1993, 67:1817-1829.
137. Zhu J., Rice P.W., Gorsch L., Abate M., Cole C.N. Transformation of a continuous rat embryo fibroblast cell line requires three separate domains of simian virus 40 large T antigen. J. Virol. 1992, 66:2780-2791.
138. Peden K.W., Srinivasan A., Farber J.M., Pipas J.M. Mutants with changes within or near a hydrophobic region of simian virus 40 large tumor antigen are defective for binding cellular protein p53. Virology 1989, 168:13-21.
139. Srinivasan A., Peden K.W., Pipas J.M. The large tumor antigen of simian virus 40 encodes at least two distinct transforming functions. J. Virol. 1989, 63:5459-5463.
140. Eckner R., Ludlow J.W., Lill N.L., Oldread E., Arany Z., Modjtahedi N., DeCaprio J.A., Livingston D.M., Morgan J.A. Association of p300 and CBP with simian virus 40 large T antigen. Mol. Cell. Biol. 1996, 16:3454-3464.
141. Lill N.L., Tevethia M.J., Eckner R., Livingston D.M., Modjtahedi N. p300 family members associate with the carboxyl terminus of simian virus 40 large tumor antigen. J. Virol. 1997, 71:129-137.
142. Lanford R.E., Butel J.S. Construction and characterization of an SV40 mutant defective in nuclear transport of T antigen. Cell 1984, 37:801-813.
143. Rundell K., Collins J.K., Tegtmeyer P., Ozer H.L., Lai C.J., Nathans D. Identification of simian virus 40 protein A. J. Virol. 1977, 21:636-646.
144. Tegtmeyer P., Rundell K., Collins J.K. Modification of simian virus 40 protein A. J. Virol. 1977, 21:647-657.
145. Scheidtmann K.H., Kaiser A., Carbone A., Walter G. Phosphorylation of threonine in the proline-rich carboxy-terminal region of simian virus 40 large T antigen. J. Virol. 1981, 38:59-69.
146. Scheidtmann K.H., Echle B., Walter G. Simian virus 40 large T antigen is phosphorylated at multiple sites clustered in two separate regions. J. Virol. 1982, 44:116-133.
147. Scheidtmann K.H., Hardung M., Echle B., Walter G. DNA-binding activity of simian virus 40 large T antigen correlates with a distinct phosphorylation state. J. Virol. 1984, 50:1-12.
148. Kalderon D., Smith A.E. In vitro mutagenesis of a putative DNA binding domain of SV40 large-T. Virology 1984, 139:109-137.
149. Mocarski E.S., Kemble G.W. Recombinant cytomegaloviruses for study of replication and pathogenesis. Intervirology 1996, 39:320-330.
150. Anders D.G., McCue L.A. The human cytomegalovirus genes and proteins required for DNA synthesis. Intervirology 1996, 39:378-388.
151. Pari G.S., Anders D.G. Eleven loci encoding trans-acting factors are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA replication. J. Virol. 1993, 67:6979-6988.
152. Weiland K.L., Oien N.L., Homa F., Wathen M.W. Functional analysis of human cytomegalovirus polymerase accessory protein. Virus Res. 1994, 34:191-206.
153. Appleton B.A., Loregian A., Filman D.J., Coen D.M., Hogle J.M. The cytomegalovirus DNA polymerase subunit UL44 forms a C clamp-shaped dimer. Mol. Cell 2004, 15:233-244.
154. Alvisi G., Ripalti A., Ngankeu A., Giannandrea M., Caraffi S.G., Dias M.M., Jans D.A. Human cytomegalovirus DNA polymerase catalytic subunit pUL54 possesses independently acting nuclear localization and ppUL44 binding motifs. Traffic 2006, 7:1322-1332.
155. Prichard M.N., Lawlor H., Duke G.M., Mo C., Wang Z., Dixon M., Kemble G., Kern E.R. Human cytomegalovirus uracil DNA glycosylase associates with ppUL44 and accelerates the accumulation of viral DNA. Virol. J. 2005, 2:55.
156. Alvisi G., Jans D.A., Ripalti A. Human cytomegalovirus (HCMV) DNA polymerase processivity factor ppUL44 dimerizes in the cytosol before translocation to the nucleus. Biochemistry 2006, 45:6866-6872.
157. Alvisi G., Rawlinson S.M., Ghildyal R., Ripalti A., Jans D.A. Regulated nucleocytoplasmic trafficking of viral gene products: a therapeutic target?. Biochim. Biophys. Acta 2008, 1784:213-227.
158. Krosky P.M., Baek M.C., Jahng W.J., Barrera I., Harvey R.J., Biron K.K., Coen D.M., Sethna P.B. The human cytomegalovirus UL44 protein is a substrate for the UL97 protein kinase. J. Virol. 2003, 77:7720-7727.
159. Marschall M., Freitag M., Suchy P., Romaker D., Kupfer R., Hanke M., Stamminger T. The protein kinase pUL97 of human cytomegalovirus interacts with and phosphorylates the DNA polymerase processivity factor pUL44. Virology 2003, 311:60-71.
160. Xiao C.Y., Jans P., Jans D.A. Negative charge at the protein kinase CK2 site enhances recognition of the SV40 large T-antigen NLS by importin: effect of conformation. FEBS Lett. 1998, 440:297-301.
161. Sinigalia E., Alvisi G., Mercorelli B., Coen D.M., Pari G.S., Jans D.A., Ripalti A., Palu G., Loregian A. Role of homodimerization of human cytomegalovirus DNA polymerase accessory protein UL44 in origin-dependent DNA replication in cells. J. Virol. 2008, 82:12574-12579.
162. St-Denis N.A., Litchfield D.W. Protein kinase CK2 in health and disease: from birth to death: the role of protein kinase CK2 in the regulation of cell proliferation and survival. Cell. Mol. Life Sci. 2009, 66:1817-1829.
163. Koffa M.D., Kean J., Zachos G., Rice S.A., Clements J.B. CK2 protein kinase is stimulated and redistributed by functional herpes simplex virus ICP27 protein. J. Virol. 2003, 77:4315-4325.
164. Souquere-Besse S., Pichard E., Filhol O., Legrand V., Rosa-Calatrava M., Hovanessian A.G., Cochet C., Puvion-Dutilleul F. Adenovirus infection targets the cellular protein kinase CK2 and RNA-activated protein kinase (PKR) into viral inclusions of the cell nucleus. Microsc. Res. Tech. 2002, 56:465-478.
165. Li S., Ku C.Y., Farmer A.A., Cong Y.S., Chen C.F., Lee W.H. Identification of a novel cytoplasmic protein that specifically binds to nuclear localization signal motifs. J. Biol. Chem. 1998, 273:6183-6189.
166. Sarfraz S., Hamid S., Ali S., Jafri W., Siddiqui A.A. Modulations of cell cycle checkpoints during HCV associated disease. BMC Infect. Dis. 2009, 9:125.
167. Guo Q., Qian L., Guo L., Shi M., Chen C., Lv X., Yu M., Hu M., Jiang G., Guo N. Transactivators Zta and Rta of Epstein-Barr virus promote G0/G1 to S transition in Raji cells: a novel relationship between lytic virus and cell cycle. Mol. Immunol. 2010, 47:1783-1792.
168. Moffat J.F., Greenblatt R.J. Effects of varicella-zoster virus on cell cycle regulatory pathways. Curr. Top. Microbiol. Immunol. 2010, 342:67-77.
169. Schang L.M. The cell cycle, cyclin-dependent kinases, and viral infections: new horizons and unexpected connections. Prog. Cell Cycle Res. 2003, 5:103-124.
170. Wang H.K., Duffy A.A., Broker T.R., Chow L.T. Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. Genes Dev. 2009, 23:181-194.
171. Whyte P., Buchkovich K.J., Horowitz J.M., Friend S.H., Raybuck M., Weinberg R.A., Harlow E. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 1988, 334:124-129.
172. Whyte P., Williamson N.M., Harlow E. Cellular targets for transformation by the adenovirus E1A proteins. Cell 1989, 56:67-75.
173. Herrmann C.H., Su L.K., Harlow E. Adenovirus E1A is associated with a serine/threonine protein kinase. J. Virol. 1991, 65:5848-5859.
174. Bollag B., Chuke W.F., Frisque R.J. Hybrid genomes of the polyomaviruses JC virus, BK virus, and simian virus 40: identification of sequences important for efficient transformation. J. Virol. 1989, 63:863-872.
175. Haggerty S., Walker D.L., Frisque R.J. JC virus-simian virus 40 genomes containing heterologous regulatory signals and chimeric early regions: identification of regions restricting transformation by JC virus. J. Virol. 1989, 63:2180-2190.
176. Harris K.F., Christensen J.B., Imperiale M.J. BK virus large T antigen: interactions with the retinoblastoma family of tumor suppressor proteins and effects on cellular growth control. J. Virol. 1996, 70:2378-2386.
177. Prichard M.N., Sztul E., Daily S.L., Perry A.L., Frederick S.L., Gill R.B., Hartline C.B., Streblow D.N., Varnum S.M., Smith R.D., Kern E.R. Human cytomegalovirus UL97 kinase activity is required for the hyperphosphorylation of retinoblastoma protein and inhibits the formation of nuclear aggresomes. J. Virol. 2008, 82:5054-5067.
178. DeCaprio J.A. The role of the J domain of SV40 large T in cellular transformation. Biologicals 1999, 27:23-28.
179. Zhang B., Chen W., Roman A. The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:437-442.
180. Hebner C.M., Laimins L.A. Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev. Med. Virol. 2006, 16:83-97.
181. de Villiers E.M. Human pathogenic papillomavirus types: an update. Curr. Top. Microbiol. Immunol. 1994, 186:1-12.
182. zur Hausen H., de Villiers E.M. Human papillomaviruses. Annu. Rev. Microbiol. 1994, 48:427-447.
183. Monsonego J., Bosch F.X., Coursaget P., Cox J.T., Franco E., Frazer I., Sankaranarayanan R., Schiller J., Singer A., Wright T.C., Kinney W., Meijer C.J., Linder J., McGoogan E., Meijer C. Cervical cancer control, priorities and new directions. Int. J. Cancer 2004, 108:329-333.
184. zur Hausen H. Papillomaviruses and cancer: from basic studies to clinical application. Nat. Rev. Cancer 2002, 2:342-350.
185. Chiang C.M., Ustav M., Stenlund A., Ho T.F., Broker T.R., Chow L.T. Viral E1 and E2 proteins support replication of homologous and heterologous papillomaviral origins. Proc. Natl. Acad. Sci. U.S.A. 1992, 89:5799-5803.
186. Sverdrup F., Khan S.A. Replication of human papillomavirus (HPV) DNAs supported by the HPV type 18 E1 and E2 proteins. J. Virol. 1994, 68:505-509.
187. Ustav M., Stenlund A. Transient replication of BPV-1 requires two viral polypeptides encoded by the E1 and E2 open reading frames. EMBO J. 1991, 10:449-457.
188. Frattini M.G., Laimins L.A. Binding of the human papillomavirus E1 origin-recognition protein is regulated through complex formation with the E2 enhancer-binding protein. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:12398-12402.
189. Frattini M.G., Laimins L.A. The role of the E1 and E2 proteins in the replication of human papillomavirus type 31b. Virology 1994, 204:799-804.
190. Kuo S.R., Liu J.S., Broker T.R., Chow L.T. Cell-free replication of the human papillomavirus DNA with homologous viral E1 and E2 proteins and human cell extracts. J. Biol. Chem. 1994, 269:24058-24065.
191. Lusky M., Hurwitz J., Seo Y.S. Cooperative assembly of the bovine papilloma virus E1 and E2 proteins on the replication origin requires an intact E2 binding site. J. Biol. Chem. 1993, 268:15795-15803.
192. Mohr I.J., Clark R., Sun S., Androphy E.J., MacPherson P., Botchan M.R. Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator. Science 1990, 250:1694-1699.
193. Sanders C.M., Stenlund A. Transcription factor-dependent loading of the E1 initiator reveals modular assembly of the papillomavirus origin melting complex. J. Biol. Chem. 2000, 275:3522-3534.
194. Sedman T., Sedman J., Stenlund A. Binding of the E1 and E2 proteins to the origin of replication of bovine papillomavirus. J. Virol. 1997, 71:2887-2896.
195. Park P., Copeland W., Yang L., Wang T., Botchan M.R., Mohr I.J. The cellular DNA polymerase alpha-primase is required for papillomavirus DNA replication and associates with the viral E1 helicase. Proc. Natl. Acad. Sci. U.S.A. 1994, 91:8700-8704.
196. Sedman J., Stenlund A. Co-operative interaction between the initiator E1 and the transcriptional activator E2 is required for replicator specific DNA replication of bovine papillomavirus in vivo and in vitro. EMBO J. 1995, 14:6218-6228.
197. Yang L., Mohr I., Fouts E., Lim D.A., Nohaile M., Botchan M. The E1 protein of bovine papilloma virus 1 is an ATP-dependent DNA helicase. Proc. Natl. Acad. Sci. U.S.A. 1993, 90:5086-5090.
198. Conger K.L., Liu J.S., Kuo S.R., Chow L.T., Wang T.S. Human papillomavirus DNA replication. Interactions between the viral E1 protein and two subunits of human DNA polymerase alpha/primase. J. Biol. Chem. 1999, 274:2696-2705.
199. Lin B.Y., Makhov A.M., Griffith J.D., Broker T.R., Chow L.T. Chaperone proteins abrogate inhibition of the human papillomavirus (HPV) E1 replicative helicase by the HPV E2 protein. Mol. Cell. Biol. 2002, 22:6592-6604.
200. Masterson P.J., Stanley M.A., Lewis A.P., Romanos M.A. A C-terminal helicase domain of the human papillomavirus E1 protein binds E2 and the DNA polymerase alpha-primase p68 subunit. J. Virol. 1998, 72:7407-7419.
201. Stenlund A. Initiation of DNA replication: lessons from viral initiator proteins. Nat. Rev. Mol. Cell Biol. 2003, 4:777-785.
202. Stubenrauch F., Laimins L.A. Human papillomavirus life cycle: active and latent phases. Semin. Cancer Biol. 1999, 9:379-386.
203. Banerjee N.S., Chow L.T., Broker T.R. Retrovirus-mediated gene transfer to analyze HPV gene regulation and protein functions in organotypic "raft" cultures. Methods Mol. Med. 2005, 119:187-202.
204. Stoler M.H., Wolinsky S.M., Whitbeck A., Broker T.R., Chow L.T. Differentiation-linked human papillomavirus types 6 and 11 transcription in genital condylomata revealed by in situ hybridization with message-specific RNA probes. Virology 1989, 172:331-340.
205. Lin B.Y., Ma T., Liu J.S., Kuo S.R., Jin G., Broker T.R., Harper J.W., Chow L.T. HeLa cells are phenotypically limiting in cyclin E/CDK2 for efficient human papillomavirus DNA replication. J. Biol. Chem. 2000, 275:6167-6174.
206. Gerlier D., Valentin H. Measles virus interaction with host cells and impact on innate immunity. Curr. Top. Microbiol. Immunol. 2009, 329:163-191.
207. Shaw M.L., Garcia-Sastre A., Palese P., Basler C.F. Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively. J. Virol. 2004, 78:5633-5641.
208. Tordo N., Poch O., Ermine A., Keith G., Rougeon F. Walking along the rabies genome: is the large G-L intergenic region a remnant gene?. Proc. Natl. Acad. Sci. U.S.A. 1986, 83:3914-3918.
209. Schnell M.J., McGettigan J.P., Wirblich C., Papaneri A. The cell biology of rabies virus: using stealth to reach the brain. Nat. Rev. Microbiol. 2010, 8:51-61.
210. Moseley G.W., Lahaye X., Roth D.M., Oksayan S., Filmer R.P., Rowe C.L., Blondel D., Jans D.A. Dual modes of rabies P-protein association with microtubules: a novel strategy to suppress the antiviral response. J. Cell Sci. 2009, 122:3652-3662.
211. Chelbi-Alix M.K., Vidy A., El Bougrini J., Blondel D. Rabies viral mechanisms to escape the IFN system: the viral protein P interferes with IRF-3, Stat1, and PML nuclear bodies. J. Interferon Cytokine Res. 2006, 26:271-280.
212. Blondel D., Regad T., Poisson N., Pavie B., Harper F., Pandolfi P.P., De The H., Chelbi-Alix M.K. Rabies virus P and small P products interact directly with PML and reorganize PML nuclear bodies. Oncogene 2002, 21:7957-7970.
213. Heilman D.W., Teodoro J.G., Green M.R. Apoptin nucleocytoplasmic shuttling is required for cell type-specific localization, apoptosis, and recruitment of the anaphase-promoting complex/cyclosome to PML bodies. J. Virol. 2006, 80:7535-7545.
214. Toriumi H., Honda Y., Morimoto K., Tochikura T.S., Kawai A. Structural relationship between nucleocapsid-binding activity of the rabies virus phosphoprotein (P) and exposure of epitope 402-13 located at the C terminus. J. Gen. Virol. 2002, 83:3035-3043.
215. Vidy A., Chelbi-Alix M., Blondel D. Rabies virus P protein interacts with STAT1 and inhibits interferon signal transduction pathways. J. Virol. 2005, 79:14411-14420.
216. Moseley G.W., Roth D.M., DeJesus M.A., Leyton D.L., Filmer R.P., Pouton C.W., Jans D.A. Dynein light chain association sequences can facilitate nuclear protein import. Mol. Biol. Cell 2007, 18:3204-3213.
217. Gupta A.K., Blondel D., Choudhary S., Banerjee A.K. The phosphoprotein of rabies virus is phosphorylated by a unique cellular protein kinase and specific isomers of protein kinase C. J. Virol. 2000, 74:91-98.
218. Shimizu K., Ito N., Sugiyama M., Minamoto N. Sensitivity of rabies virus to type I interferon is determined by the phosphoprotein gene. Microbiol. Immunol. 2006, 50:975-978.
219. Kulkarni S., Volchkova V., Basler C.F., Palese P., Volchkov V.E., Shaw M.L. Nipah virus edits its P gene at high frequency to express the V and W proteins. J. Virol. 2009, 83:3982-3987.
220. Rodriguez J.J., Parisien J.P., Horvath C.M. Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation. J. Virol. 2002, 76:11476-11483.
221. Ciancanelli M.J., Volchkova V.A., Shaw M.L., Volchkov V.E., Basler C.F. Nipah virus sequesters inactive STAT1 in the nucleus via a P gene-encoded mechanism. J. Virol. 2009, 83:7828-7841.
222. Caignard G., Guerbois M., Labernardiere J.L., Jacob Y., Jones L.M., Wild F., Tangy F., Vidalain P.O. Measles virus V protein blocks Jak1-mediated phosphorylation of STAT1 to escape IFN-alpha/beta signaling. Virology 2007, 368:351-362.
223. Ohno S., Ono N., Takeda M., Takeuchi K., Yanagi Y. Dissection of measles virus V protein in relation to its ability to block alpha/beta interferon signal transduction. J. Gen. Virol. 2004, 85:2991-2999.
224. Palosaari H., Parisien J.P., Rodriguez J.J., Ulane C.M., Horvath C.M. STAT protein interference and suppression of cytokine signal transduction by measles virus V protein. J. Virol. 2003, 77:7635-7644.
225. Nanda S.K., Baron M.D. Rinderpest virus blocks type I and type II interferon action: role of structural and nonstructural proteins. J. Virol. 2006, 80:7555-7568.